Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-20-005764
Filing Date
2020-05-07
Accepted
2020-05-07 16:52:35
Documents
5
Effectiveness Date
2020-05-07

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20200507xs8.htm S-8 157882
2 EX-5.1 tmb-20200507xex5d1.htm EX-5.1 8915
3 EX-23.1 tmb-20200507xex23d1.htm EX-23.1 5434
4 GRAPHIC tmb-20200507xex5d1g001.jpg GRAPHIC 14083
5 GRAPHIC tmb-20200507xex5d1g002.jpg GRAPHIC 10523
  Complete submission text file 0001558370-20-005764.txt   207490
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Filer) CIK: 0001724344 (see all company filings)

EIN.: 824592913 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-238076 | Film No.: 20857307
SIC: 2834 Pharmaceutical Preparations